Neurotropic and neuroinvasive capabilities of coronaviruses have been described in humans. Neurological problems found in patients with coronavirus infection include: febrile seizures, convulsions, loss of consciousness, encephalomyelitis, and encephalitis. Coronavirus disease (COVID-19) is caused by SARS-CoV2. In severe cases, patients may develop severe pneumonia, acute respiratory distress syndrome, and acute cardiac injury. While seizures and status epilepticus have not been widely reported in the past five months since the onset of COVID-19 pandemic, patients with COVID-19 may have hypoxia, multiorgan failure, and severe metabolic and electrolyte disarrangements; hence, it is plausible to expect clinical or subclinical acute symptomatic seizures to happen in these patients. One should be prepared to treat seizures appropriately, if they happen in a patient who is already in a critical medical condition and suffers from organ failure.

• Seizures have been reported in patients with various coronavirus infections.
• However, seizures seem to be a rare occurrence in people with COVID-19.
• Patients with COVID-19 may have hypoxia, multiorgan failure, and metabolic disarrangements.
• It is plausible to expect acute symptomatic seizures to happen in these patients.
• One should be prepared to treat seizures appropriately.

Share your valuable research in our Journal of Biochemistry & Biotechnology is an open-access journal dedicating the research in the area of biochemistry & biotechnology. We have been publishing the articles which are having updated information on biological science.

Allied Academics is one of the leading publishers operates a journal portfolio focusing on biomedical, environment, finance and marketing subjects. The main aim is to publish Original, peer-reviewed articles, Review articles, Short Communication, Editorials, Case Reports etc., following internationally recognized standard editorial guidelines, publication ethics, and production policies. Several authors affiliated to reputed organizations, institutions, government bodies have published their valuable contributions with Allied Academies.

The manuscripts may be submitted as an attachment to biochembiotech@scholarlypub.com, biochemistry@biochemjournals.com

Regards,
Nicola B
Editorial Team
Journal of  Biochemistry and Biotechnology
WhatsApp: +44 1470-490003